The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lanreotide for advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in a Korean population: A multicenter prospective observational study (AIM-NETs).
 
Changhoon Yoo
Stock and Other Ownership Interests - OncoCross
Honoraria - AstraZeneca; Boehringer Ingelheim; Boryung Pharmaceuticals; Bristol-Myers Squibb; Eisai; Elevar therapeutics; Ipsen; MSD Oncology; Novartis; SERVIER
Consulting or Advisory Role - Abbisko Therapeutics; Qurient
Research Funding - AstraZeneca; Boehringer Ingelheim; Boryung Pharmaceuticals; Eisai; Lunit
 
Choong-kun Lee
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Roche; SERVIER
Speakers' Bureau - Astellas Pharma; Boryung Pharmaceuticals; Celgene/Bristol-Myers Squibb; Ono Pharmaceutical; SERVIER; Yuhan
Research Funding - Boryung Pharmaceuticals (Inst); GC Biopharma (Inst); Idience (Inst); Ono Pharmaceutical (Inst); Selecxine (Inst)
 
Baek-Yeol Ryoo
No Relationships to Disclose
 
Kyu-pyo Kim
No Relationships to Disclose
 
Jaekyung Cheon
Research Funding - Bayer
 
Hyehyun Jeong
No Relationships to Disclose
 
Seung-Mo Hong
No Relationships to Disclose
 
Yong-il Kim
No Relationships to Disclose
 
Jin-Sook Ryu
No Relationships to Disclose
 
Ji Sung Lee
No Relationships to Disclose
 
Hye Jin Choi
Consulting or Advisory Role - AstraZeneca; MSD Oncology
 
Ji-Won Kim
No Relationships to Disclose
 
Woochan Park
No Relationships to Disclose
 
Minsu Kang
No Relationships to Disclose
 
Myung Ah Lee
Honoraria - Merck; Takeda
Consulting or Advisory Role - Green Cross; Handok; onconic therapeutics
 
Jin Won Kim
Consulting or Advisory Role - AstraZeneca; BeiGene Beijing; BeiGene Beijing; BeyondBIO; Bristol-Myers Squibb/Celgene; Eisai; GC Cell; MSD; Ono Pharmaceutical; Roche; Sanofi; Servier; TCUBEit
Research Funding - Boryung Pharmaceuticals; Samyang